11
S 9. Supplement S 9.1. Limits of detection and quantification The chemical analysis procedure established the detection and quantification limits to create a min- imum signal-to-noise ratio of 3 and 10, respectively. This resulted in the limits presented in Table S.1. The amount of censoring for each municipality-drug combination is in Table S.2. Meth MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone LOD 1.5 1.0 1.0 2.0 2.0 2.0 LOQ 10.0 2.5 10.0 2.5 2.5 2.5 Note: Meth = methamphetamine Table S.1: Detection and quantification limits (ng/L) S 9.2. Sampled WWTPs The 19 treatment plants contributing data for this analysis represent a convenience sample of diverse systems in the Northwest United States, specifically in the states of Washington and Oregon. The given WWTP names are a mix of neighborhood names, city names, or collective names or otherwise convenient labels that may or may not accurately reflect the catchment area served. We use the term “municipality” in general to indicate the WWTP and the area served. While most municipalities are along the main north-south transportation corridor (US Interstate 5), several locations represent smaller cities or towns along the coast or inland in the drier regions east of the Cascade mountain range. The relative population sizes covered by each WWTP and their representative level of precipitation for 2009 are presented in Figure S.1. The final (average for Seattle and Renton; see Section 3.1) population estimates and the source of those estimates, per the WWTP surveys, are in the second and third columns of Table S.2. S 9.3. Sample data setup Calculating a given sample’s index load requires four parameters: the measured concentration (column 1 in Table S.3), the titration correction factor to account for titrating the sample to facilitate measurement (column 2), the day’s measured flow through the WWTP (column 3), and the day’s population estimate (column 6, constant in this example; see Section 3.1 for discussion of how this value might vary). The “Final Concentration” and “Final Load” columns (4 and 5) in the sample data setup are intermediate calculations that represent the titration-corrected concentration and the product of this concentration and the day’s volume. For the third and fourth rows, the initial concentrations are censored. For estimating the mean index load in the presence of censoring via a survival analysis method, the censoring must be represented as intervals to indicate the range the values could take. The final two columns, here labeled “Left” and “Right” (your software may prefer “Begin” and “End”, etc.), are what are inputted to the estimating software. For measurable observations, the two sides of this interval are the calculated index load. For values below the level of detection (<LOD, where the LOD in the example is 1.5), the left side of the interval is 0 and the right side is the LOD×titration factor×flow÷population÷(1000 2 ), to reflect that the initial concentration must be in the range of 0 to 1.5. For values below the level of quantification (<LOQ, where LOQ here is 10.0), we only know the initial concentration is between the LOD and the LOQ, and so the two sides of the interval reflect these values multiplied through: E.g., LOQ×titration factor×flow÷population÷(1000 2 ). S 9.4. Robust retransformation After maximum likelihood estimation, implemented with 50–80% censoring, we apply a robust retrans- formation to avoid retransformation bias as described by Helsel (2012), Kroll and Stedinger (1996), and Shumway, Azari, and Kayhanian (2002). In order to create the distribution graphs in Figures 1, S.2, and S.3, we also apply Steps 1–4 below for cases with less than 50% censoring. Given data as in the example above (Table S.3), the primary goal is to have an unbiased estimate of the mean of the data, and the

S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

S 9. Supplement

S 9.1. Limits of detection and quantification

The chemical analysis procedure established the detection and quantification limits to create a min-imum signal-to-noise ratio of 3 and 10, respectively. This resulted in the limits presented in Table S.1.The amount of censoring for each municipality-drug combination is in Table S.2.

Meth MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone

LOD 1.5 1.0 1.0 2.0 2.0 2.0LOQ 10.0 2.5 10.0 2.5 2.5 2.5

Note: Meth = methamphetamine

Table S.1: Detection and quantification limits (ng/L)

S 9.2. Sampled WWTPs

The 19 treatment plants contributing data for this analysis represent a convenience sample of diversesystems in the Northwest United States, specifically in the states of Washington and Oregon. The givenWWTP names are a mix of neighborhood names, city names, or collective names or otherwise convenientlabels that may or may not accurately reflect the catchment area served. We use the term “municipality”in general to indicate the WWTP and the area served. While most municipalities are along the mainnorth-south transportation corridor (US Interstate 5), several locations represent smaller cities or townsalong the coast or inland in the drier regions east of the Cascade mountain range. The relative populationsizes covered by each WWTP and their representative level of precipitation for 2009 are presented inFigure S.1. The final (average for Seattle and Renton; see Section 3.1) population estimates and thesource of those estimates, per the WWTP surveys, are in the second and third columns of Table S.2.

S 9.3. Sample data setup

Calculating a given sample’s index load requires four parameters: the measured concentration (column1 in Table S.3), the titration correction factor to account for titrating the sample to facilitate measurement(column 2), the day’s measured flow through the WWTP (column 3), and the day’s population estimate(column 6, constant in this example; see Section 3.1 for discussion of how this value might vary). The“Final Concentration” and “Final Load” columns (4 and 5) in the sample data setup are intermediatecalculations that represent the titration-corrected concentration and the product of this concentrationand the day’s volume.

For the third and fourth rows, the initial concentrations are censored. For estimating the mean indexload in the presence of censoring via a survival analysis method, the censoring must be represented asintervals to indicate the range the values could take. The final two columns, here labeled “Left” and“Right” (your software may prefer “Begin” and “End”, etc.), are what are inputted to the estimatingsoftware. For measurable observations, the two sides of this interval are the calculated index load. Forvalues below the level of detection (<LOD, where the LOD in the example is 1.5), the left side of theinterval is 0 and the right side is the LOD×titration factor×flow÷population÷(10002), to reflect thatthe initial concentration must be in the range of 0 to 1.5. For values below the level of quantification(<LOQ, where LOQ here is 10.0), we only know the initial concentration is between the LOD and theLOQ, and so the two sides of the interval reflect these values multiplied through: E.g., LOQ×titrationfactor×flow÷population÷(10002).

S 9.4. Robust retransformation

After maximum likelihood estimation, implemented with 50–80% censoring, we apply a robust retrans-formation to avoid retransformation bias as described by Helsel (2012), Kroll and Stedinger (1996), andShumway, Azari, and Kayhanian (2002). In order to create the distribution graphs in Figures 1, S.2, andS.3, we also apply Steps 1–4 below for cases with less than 50% censoring. Given data as in the exampleabove (Table S.3), the primary goal is to have an unbiased estimate of the mean of the data, and the

Page 2: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

Bend

Pasco

Euge

neOn

tario

Everet

t

Tri-Ci

tyPo

rtland

Aberd

een

Corva

llis

Herm

iston

Gran

ts Pa

ss

Port A

ngele

s

Klama

th Fa

lls

System

popu

lation

10,00

010

0,000

500,0

001,0

00,00

0

Total

prec

ipitat

ion (in

)9.3

5 - 10

.5710

.57 - 1

3.53

13.53

- 16.8

216

.82 - 2

2.39

22.39

- 28.2

728

.27 - 3

5.07

35.07

- 43.6

043

.60 - 4

9.20

49.20

- 83.3

583

.35 - 1

01.45

Tacom

aLako

taRento

n

Olymp

ia

Redo

ndo

Seatt

le

Everet

tPu

get S

ound

Regio

n

Waste

water

syste

ms w

ith as

socia

ted po

pulat

ion si

ze, 2

009 p

recipi

tation

by N

OAA c

limate

divis

ion

®F

igu

reS

.1:

WW

TP

sw

ith

esti

mate

dp

op

ula

tion

an

d2009

pre

cip

itati

on

by

Nati

on

al

Oce

an

ogra

ph

ican

dA

tmosp

her

icA

dm

inis

trati

on

clim

ate

div

isio

n

Page 3: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

Pop

ula

tion

esti

mat

eM

eth

amp

het

amin

eM

DM

AB

enzo

yle

cgon

ine

Met

had

one

Hyd

roco

don

eO

xyco

don

eW

WT

PS

ourc

eF

inal

NC

enso

red

NC

enso

red

NC

enso

red

NC

enso

red

NC

enso

red

NC

enso

red

Ab

erd

een

Cen

sus

211

7042

043

81.4

%43

043

042

9.5%

422.4

%B

end

Cen

sus

8548

048

054

3.7%

540

540

541.

9%53

0C

orva

llis

stat

e59

562.

5655

052

55.8

%52

28.8

%53

22.6

%52

11.5

%53

7.5

%E

uge

ne

NA

#23

4300

51

055

7.3%

553.

6%

550

551.

8%55

0E

vere

ttN

A#

1265

35.5

46

053

24.5

%52

052

052

052

0G

rants

Pas

sco

nn

ecti

ons

4600

050

053

50.9

%44

053

054

054

0H

erm

isto

nst

ate

1665

3.6

530

5294

.2%

520

520

520

520

Kla

mat

hF

alls

Cen

sus

3285

2.87

52

052

51.9

%53

50.9

%52

052

053

0L

akot

aN

A735

2854

053

67.9

%53

053

053

1.9%

530

Oly

mp

iaco

nn

ecti

ons

9800

055

052

57.7

%52

1.9%

520

5230

.8%

5315.1

%O

nta

rio

NA

#13

516.

943

055

92.7

%55

23.6

%55

055

0.0

%55

0P

asco

stat

e53

304.

05

520

5244

.2%

520

527.

7%53

3.8%

512.0

%P

ort

Ange

les

Cen

sus

2084

4.1

53

055

72.7

%53

7.5%

531.

9%53

9.4%

531.9

%P

ortl

an

dst

ate

6378

42.5

540

4332

.6%

429.

5%40

043

11.6

%43

18.6

%R

edon

do

NA

3555

253

1.9

%48

43.8

%48

048

034

2.9%

480

Ren

ton

NA

9385

35.9

500

4647

.8%

460

462.

2%46

19.6

%46

10.9

%S

eatt

leN

A84

1326

.353

050

16.0

%50

050

050

20.0

%50

16.0

%T

acom

aN

A#

1780

86.6

530

508.

0%50

050

050

4.0%

500

Tri

-Cit

yco

nn

ecti

ons

8715

254

054

61.1

%54

054

054

054

0

Note:

Nis

nu

mb

erof

sam

ple

sav

aila

ble

for

anal

ysi

s.N

Ain

pop

ula

tion

esti

mat

eso

urc

ein

dic

ates

mis

sin

gso

urc

e;N

A#

ind

icat

esC

ensu

s-b

ased

day

tim

ep

opu

lati

onad

just

men

tu

sed

.S

eatt

lean

dR

ento

np

opu

lati

on

sin

dic

ate

aver

age

acro

ssal

lsa

mp

led

day

s;ot

her

sp

opu

lati

ons

con

stan

t.

Tab

leS

.2:

Pop

ula

tion

esti

mate

san

dce

nso

rin

gof

sam

ple

sby

WW

TP

Page 4: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

12

34

56

78

9

Mea

sure

dT

itra

tion

Fin

alF

inal

Ind

exC

on

centr

atio

nC

orre

ctio

nF

low

Con

centr

atio

nL

oad

Loa

d(n

g/L

)F

acto

r(L

/d

ay)

(ng/

L)

(gra

ms)

Pop

ula

tion

(mg/

per

son

/day

)L

eft

Rig

ht

1005

.21.

0767

1726

1424

1082

.318

.682

211

650.

8827

0.88

270.

8827

1782

.01.0

538

1131

8346

1877

.921

.254

211

651.

0042

1.00

421.

0042

<L

OD

1.05

6015

3752

6821

165

0.00

000.

0012

<L

OQ

1.04

90155

6849

521

165

0.00

120.

0077

Tab

leS

.3:

Sam

ple

data

setu

pfo

rsu

bst

an

cew

ith

LO

Dof

1.5

ng/L

an

dL

OQ

of

10

ng/L

Page 5: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

secondary goal to have a full hypothetical dataset to create boxplots. The robust retransformation isimplemented as follows:

Step 1 Take the estimated distribution of the transformed data and place the censored data in appro-priate places on the lower part of the distribution. These plotting positions or percentiles areessentially evenly spaced in the lower end of the distribution, on the transformed scale.

• Specifically, for each censored observation i among all c censored observations within the Nobservations, the plotting position p is given by

p =c

i− 38

c + 14

(4)

where the i for observations below LOD come before the i for observations above LOD butbelow LOQ.

Step 2 Translate the percentiles into values on the transformed scale via the normal distribution quantilefunction.

Step 3 Individually re-transform these predicted values on the transformed scale to the original scale.

Step 4 Combine these predicted values with the original observed values (i.e. the uncensored values)into a new set of data.

Step 5 Calculate the mean of this hypothetical data.

S 9.5. Distributions and estimates for other analytes

Following the discussion of censoring, distribution, error components, and estimates for metham-phetamine and MDMA in the main text, here we present the graphical results for the other analytesconsidered: benzoylecgonine, methadone, hydrocodone, and oxycodone. In the boxplot graphs, the shad-ing of the box represents the amount of censoring for each municipality-drug combination, with darkerboxes indicating more complete data. The WWTPs are ordered by the completeness of the data andthen alphabetically. The background shading and label (Report censoring, MLE, KM, Complete data)indicate for groups of municipality-drugs what method was used to create the estimate in the corre-sponding estimates graphs. In the latter, the shading of the estimate indicator (the diamond) representsthe amount of censoring, and the dotted line the unweighted average estimate across the 19 WWTPs.WWTPs are ordered by the mean annual estimate.

S 9.6. Sensitivity of confidence intervals to changes in US

As described in the Discussion, our annual sampling error estimate of US = 10% came from a study ofsampling (or monitoring) uncertainty in a small European city (Ort et al., 2014a). That exercise involvedrepeated samples of N = 56 taken from over 1000 consecutive daily samples of benzoylecgonine (cocainemetabolite). With fewer than 56 samples in the current analysis, WWTP catchment area sizes of moreor less than 7000 users, and substances that may have more or less variation in use than cocaine, one mayquestion whether a different estimate of annual sampling error might change the results substantially.In Figure S.6, we present the estimates and confidence intervals for a single substance, MDMA, in whichwe have both doubled our sampling uncertainty RSD (top panel) and halved it (bottom panel). (Similargraphs for the other analytes are available upon request.) Compared to the bottom panel of Figure 2,we see that changing one of our four uncertainty parameters has small effects on the resulting CIs. Witha 5% uncertainty, Port Angeles MDMA becomes more clearly significantly higher than average, but weremain uncertain that Renton MDMA could not be essentially 0. With less certainty about the abilityof our 43 to 55 samples to represent the whole year—US = 20%—Port Angeles MDMA levels are clearlynot significantly different than the average, and Tacoma’s CI is more likely to overlap with any otherWWTP CI, but all except the Renton index load remain significantly greater than 0. Compared withboth the size of the CIs and the differences in estimated means, these changes in CI due to differentannual sampling uncertainties are relatively small.

Page 6: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

MLE

KM

Com

plet

e da

ta

0.442.23.9mg/person/day

Kla

mat

h Fa

llsO

ntar

ioP

ort A

ngel

esO

lym

pia

Ben

dG

rant

s P

ass

Lako

taR

edon

doS

eattl

eTr

i−C

ityC

orva

llis

Por

tland

Eug

ene

Abe

rdee

nE

vere

ttH

erm

isto

nP

asco

Ren

ton

Taco

ma

BE

NZ

OY

LEC

GO

NIN

E b

ox s

hadi

ng:

80%

cen

sore

d50

% c

enso

red

No

cens

orin

g

KM

Com

plet

e da

ta

0.0280.140.25mg/person/day

Cor

valli

sR

ento

nA

berd

een

Eug

ene

Gra

nts

Pas

sK

lam

ath

Falls

Oly

mpi

aP

ortla

ndS

eattl

eTr

i−C

ityP

asco

Por

t Ang

eles

Ben

dE

vere

ttH

erm

isto

nLa

kota

Ont

ario

Red

ondo

Taco

ma

ME

TH

AD

ON

E

Fig

ure

S.2

:B

enzo

yle

cgon

ine

(top

)an

dm

eth

ad

on

e(b

ott

om

)in

dex

load

dis

trib

uti

on

(mg/p

erso

n/d

ay)

Page 7: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

KM

Com

plet

e da

ta

0.0310.150.27mg/person/day

Oly

mpi

aR

ento

nC

orva

llis

Por

t Ang

eles

Pas

coLa

kota

Eug

ene

Gra

nts

Pas

sK

lam

ath

Falls

Tri−

City

Sea

ttle

Por

tland

Abe

rdee

nTa

com

aR

edon

doB

end

Eve

rett

Her

mis

ton

Ont

ario

HY

DR

OC

OD

ON

E b

ox s

hadi

ng:

80%

cen

sore

d50

% c

enso

red

No

cens

orin

g

KM

Com

plet

e da

ta

0.0630.310.57mg/person/day

Por

tland

Oly

mpi

aC

orva

llis

Pas

coB

end

Eve

rett

Her

mis

ton

Lako

taR

edon

doTr

i−C

ityS

eattl

eR

ento

nA

berd

een

Por

t Ang

eles

Eug

ene

Gra

nts

Pas

sK

lam

ath

Falls

Ont

ario

Taco

ma

OX

YC

OD

ON

E

Fig

ure

S.3

:H

yd

roco

don

e(t

op

)an

doxyco

don

e(b

ott

om

)in

dex

load

dis

trib

uti

on

(mg/p

erso

n/d

ay)

Page 8: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

0.170.851.5mg/person/day

Kla

mat

h Fa

llsG

rant

s P

ass

Oly

mpi

aA

berd

een

Por

t Ang

eles

Cor

valli

sP

ortla

ndP

asco

Sea

ttle

Eve

rett

Ont

ario

Ben

dH

erm

isto

nE

ugen

eTr

i−C

ityR

ento

nLa

kota

Red

ondo

Taco

ma

5355

4454

5252

4355

5354

5246

4253

5248

5050

52N

T

mea

n (0

% c

enso

red)

mea

n (6

0% c

enso

red)

95%

CI

aver

age

mea

n

BE

NZ

OY

LEC

GO

NIN

E

0.0130.0650.12mg/person/day

Pas

coH

erm

isto

nC

orva

llis

Ren

ton

Oly

mpi

aE

ugen

eS

eattl

eA

berd

een

Gra

nts

Pas

sP

ort A

ngel

esB

end

Ont

ario

Lako

taK

lam

ath

Falls

Tri−

City

Por

tland

Red

ondo

Taco

ma

Eve

rett

5254

5255

5353

4652

5254

5540

5048

4350

5352

53N

ME

TH

AD

ON

E

Fig

ure

S.4

:B

enzo

yle

cgon

ine

(top

)an

dm

eth

ad

on

e(b

ott

om

)in

dex

load

mea

nw

ith

95%

con

fid

ence

inte

rval

(mg/p

erso

n/d

ay)

Page 9: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

0.00810.040.073mg/person/day

Ren

ton

Oly

mpi

aR

edon

doB

end

Eug

ene

Taco

ma

Por

t Ang

eles

Tri−

City

Kla

mat

h Fa

llsG

rant

s P

ass

Sea

ttle

Lako

taP

asco

Por

tland

Cor

valli

sH

erm

isto

nA

berd

een

Ont

ario

Eve

rett

4650

5253

3453

5443

5552

5052

5342

5455

5252

54N

T

mea

n (0

% c

enso

red)

mea

n (6

0% c

enso

red)

95%

CI

aver

age

mea

n

HY

DR

OC

OD

ON

E

0.0220.110.2mg/person/day

Pas

coO

lym

pia

Kla

mat

h Fa

llsP

ortla

ndC

orva

llis

Lako

taR

edon

doTa

com

aA

berd

een

Eve

rett

Ben

dH

erm

isto

nO

ntar

ioR

ento

nS

eattl

eE

ugen

eTr

i−C

ityG

rant

s P

ass

Por

t Ang

eles

5153

5352

5355

4346

5350

5355

4854

5054

4253

52N

OX

YC

OD

ON

E

Fig

ure

S.5

:H

yd

roco

don

e(t

op

)an

doxyco

don

e(b

ott

om

)in

dex

load

mea

nw

ith

95%

con

fid

ence

inte

rval

(mg/p

erso

n/d

ay)

Page 10: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

>80

%ce

nsor

ing

10%50%90%●

0.0030.0150.027

mg/person/day

Abe

rdee

nO

ntar

ioLa

kota

Kla

mat

h Fa

llsO

lym

pia

Por

tland

Red

ondo

Sea

ttle

Eug

ene

Taco

ma

Her

mis

ton

Pas

coG

rant

s P

ass

Tri−

City

Cor

valli

sR

ento

nB

end

Por

t Ang

eles

Eve

rett

4352

5552

5353

5254

5252

4346

4854

5055

5553

50N

● ●

< L

OD

< L

OQ

MD

MA

, SA

MP

LIN

G U

NC

ER

TAIN

TY

= 2

0%

>80

%ce

nsor

ing

10%50%90%

0.0030.0150.027

mg/person/day

Abe

rdee

nO

ntar

ioLa

kota

Kla

mat

h Fa

llsO

lym

pia

Por

tland

Red

ondo

Sea

ttle

Eug

ene

Taco

ma

Her

mis

ton

Pas

coG

rant

s P

ass

Tri−

City

Cor

valli

sR

ento

nB

end

Por

t Ang

eles

Eve

rett

4352

5552

5353

5254

5252

4346

4854

5055

5553

50N

● ●

< L

OD

< L

OQ

MD

MA

, SA

MP

LIN

G U

NC

ER

TAIN

TY

= 5

%

Fig

ure

S.6

:M

DM

Ain

dex

load

mea

nw

ith

95%

con

fid

ence

inte

rval

(mg/p

erso

n/d

ay)

base

don

an

nu

al

sam

plin

ger

ror

of

20%

(top

)an

d5%

(bott

om

)

Page 11: S 9. Supplement · 2019. 10. 31. · Population estimate Methamphetamine MDMA Benzoylecgonine Methadone Hydrocodone Oxycodone WWTP Source Final N Censored N Censored N Censored N

S 9.7. Observation variability and population size

Figure S.7: Variability of daily drug loads [as coefficient of variation (CV)] vs. population size (P, in 1000s) in five differentcatchments for different substances (duration of studies in days: 1©=1369, 2©=311, 3©=28, 4©=239, 5©=28/35). Reasonsfor CVs exceeding 0.8 in theses studies are: i) observations below limit of quantification (heroin) and ii) pronounced intra-week variability (MDMA). Such a regular weekend effect causes a high CV but does not imply that more samples wouldbe needed for the same acceptable uncertainty. Adapted from European Monitoring Centre for Drugs and Drug Addiction(2016).

Reference

European Monitoring Centre for Drugs and Drug Addiction, Assessing Illicit Drugs in

Wastewater: Advances in Wastewater-based Drug Epidemiology (Insights 22), 2016,

Publications Office of the European Union; Luxembourg, http://dx.doi.org/10.2810/6622.